The study maps the epitopes of several monoclonal antibodies against AAV-2 capsids, identifying specific domains involved in viral binding and neutralization.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for AAV vector engineering; leaves open translation to human gene therapy applications.
Wobus et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: